DrugInformer Search


Average User Review Score
* Based on 0 reviews from across the web.

Naphcon-A is a brand of eye drops produced by Alcon Laboratories, Inc., a pharmaceutical products company based in Fort Worth, Texas. It is said to relieve the symptoms of itchy red eyes.

Read more on Wikipedia

  Please use Workbench for in-depth research on Naphcon-a.

* Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients.

Tell us about your Experience with Naphcon-a

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: None

Posted By LittleBirdsNest in twitter.com on April 26, 2014 @ 12:00 am

Naphcon-A drops are good for that. It's weird, I don't always suffer allergies but this year is already awful

Druginformer Identified Side Effects: None

Posted By AllergiesSuck in ehealthforum.com on March 24, 2012 @ 12:00 am

Allergic Conjunctivitis Treatment ***SOLVED*** Thanks to Shayna! Web MD - Allergic Conjunctivitis Symptoms Redness in the white of the eye or inner eyelid Increased amo...

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.